Prevalence and Clinical Characteristics of Calciphylaxis in Chinese Hemodialysis Patients
Related Experiment Video
Updated: Sep 6, 2025

A Semi-Automated and Reproducible Biological-Based Method to Quantify Calcium Deposition In Vitro
Published on: June 2, 2022
Yuqiu Liu1, Canlin Yang1, Xin Yang1
1Institute of Nephrology, Zhong Da Hospital, School of Medicine, Southeast University, Nanjing, China.
Insights
The first China-based survey found calciphylaxis prevalence at 1.24% in hemodialysis patients. Early screening using multiple diagnostic methods is crucial for this severe vascular disease.
Area of Science:
- Vascular Medicine
- Epidemiology
- Nephrology
Background:
- Calciphylaxis is a severe, life-threatening vascular disease predominantly affecting patients undergoing dialysis.
- This study represents the first epidemiological survey of calciphylaxis in China.
Purpose of the Study:
- To determine the prevalence of calciphylaxis among hemodialysis patients in China.
- To identify risk factors associated with calciphylaxis in this population.
Main Methods:
- A cross-sectional survey was conducted in 24 dialysis centers in Jiangsu Province.
- 3,867 adult hemodialysis patients (dialysis duration > 6 months) were included.
- Diagnosis was based on characteristic skin lesions and histopathological features; skin biopsy and bone scintigraphy were utilized.
Main Results:
- The prevalence of calciphylaxis was found to be 1.24% (48 out of 3,867 patients).
- High prevalence of hyperparathyroidism (72.92%) was observed in calciphylaxis patients.
- Risk factors identified include increased BMI, prolonged dialysis, warfarin therapy, hyperparathyroidism, diabetes, tumors, low serum albumin, and high serum alkaline phosphatase.
Conclusions:
- The study establishes a baseline prevalence of 1.24% for calciphylaxis in Chinese hemodialysis patients.
- The actual prevalence may be underestimated, highlighting the need for improved clinical awareness.
- Multifaceted diagnostic approaches are recommended for early calciphylaxis screening.
Background:
Calciphylaxis is a grievous life-threatening vascular disease that commonly affects dialysis population. This is the first epidemiological survey of calciphylaxis initiated in China.
Methods:
In the cross-sectional survey, a stratified sampling method was used to select 24 dialysis centers in Jiangsu Province. The participants were all adult patients in each center who had been on hemodialysis for more than 6 months. Calciphylaxis patients were uniformly diagnosed based on characteristic skin lesions and histopathological features.
Results:
A total of 3,867 hemodialysis patients (average age of 55.33 ± 13.89 years; 61.81% of males) were included. Forty eight cases were diagnosed with calciphylaxis, and prevalence was 1.24%. Among calciphylaxis patients, 33 cases were male, and the average age and median dialysis duration were 53.85 ± 15.17 years and 84.00 (48.00, 138.75) months, respectively. Skin biopsy was performed in 70.83% of calciphylaxis patients, and positive rate was 64.71%. Meanwhile, the positive rate of bone scintigraphy in the diagnosis of calciphylaxis was 62.5%. The prevalence of hyperparathyroidism in case group was as high as 72.92% with longer duration, and 42.86% had undergone parathyroidectomy. Multivariate analysis indicated that increased BMI, prolonged dialysis duration, warfarin therapy, hyperparathyroidism, diabetes, tumors, low serum albumin and high serum alkaline phosphatase levels were high-risk factors for calciphylaxis.
Conclusions:
The prevalence of calciphylaxis in Chinese hemodialysis patients was 1.24% according to regional epidemiological survey, but its actual prevalence would be presumably far beyond present data. It's urgent to improve clinical understanding of calciphylaxis, and multifaceted diagnostic methods should be applied for early screening.
Related Concept Videos
Chronic Kidney Disease II: Clinical Manifestations
Hemodialysis II: Procedure and Complications
Chronic Kidney Disease I: Introduction
Chronic Kidney Disease III: Interprofessional Care
Urinary Tract Calculi II: Pathophysiology and Clinical Manifestations
Hemodialysis I: Introduction

